Other executives

 

Composition of the Executive Management Board
as of 1 January 2012

Timo Lappalainen

President and CEO of Orion Corporation, Chairman of Executive Management Board 1)

Satu Ahomäki

Senior Vice President, Global Sales

Markku Huhta-Koivisto

Senior Vice President, Specialty Products and Fermion

Olli Huotari

Senior Vice President, Corporate Functions

Liisa Hurme

Senior Vice President, Proprietary Products

Jari Karlson

Chief Financial Officer, Vice President, Animal Health

Virve Laitinen

Senior Vice President, Supply Chain

Reijo Salonen

Senior Vice President, Research and Development

 

1) Timo Lappalainen also represents Orion Diagnostica in the Executive Management Board

The employees are represented in the Executive Management Board by Liisa Remes.

 

The role and responsibilities of the Executive Management Board are described in section  Group level>>.

Up-to-date information on the holdings of the members of the Executive Management Board is available in the Register of Insiders of the Orion Group, at www.orion.fi/insider-register.

 

Introduction of the Executive Management Board members

 

 

Timo Lappalainen
M.Sc. (Eng) 
b. 1962

 

President and CEO of Orion Corporation,
Chairman of the Executive Management Board

as of 1 January 2008

 

 

Career

Timo Lappalainen joined Orion in 1999. He has since occupied the following positions:

2008–           President and CEO

2005–2007  Senior Vice President, Proprietary Products and Animal Health
2003–2005  Executive Vice President, Orion Pharma
1999–2003  Senior Vice President, Business Development
 

1994–1999  Leiras Oy, Vice President, International Marketing and Business
                       Development
1989–1993  Finvest Ltd., Vice President, Business Development and General
                       Manager of Finvest’s German unit
1987–1988  Arthur Andersen & Co. (Chicago, USA), Consultant

 

Current key positions of trust

Member of the Board: Vaisala Oyj 2011–, Chemical Industry Federation of Finland 2008–, Finnish Foundation for Cardiovascular Research 2010–
Member of the Advisory Board: The Finnish Fair Corporation 2009–

 

In addition, Timo Lappalainen a member of the Council of the Helsinki Region Chamber of Commerce and a member of the Council of the Finnish Section of the International Chamber of Commerce (ICC Finland).

 

 

 


Satu Ahomäki 
M.Sc. (Econ.)
b. 1966 

Senior Vice President, Global Sales, since 1 October 2010

 

 

  

 

Career

Satu Ahomäki joined Orion in 1992. She has since occupied the following positions:

2010–           Senior Vice President, Global Sales

2008–2010  Senior VP, Animal Health
2006–2007  Head of Business Development
2005              Business Development Director
2000–2004  Project Manager and Program Leader of Hormonal and Urological
                       therapies
1992–1999  Several duties in pharmaceutical R&D

 

Before joining Orion, Satu Ahomäki worked in accounting in different companies.

 


 

 

Markku Huhta-Koivisto
M.Sc. (Eng.), MBA
b. 1956

Senior Vice President, Specialty Products and Fermion, since 1 November 2006

 

  

Career

Markku Huhta-Koivisto joined Orion in 1982. He has since occupied the following positions:

2006–           Senior Vice President, Specialty Products and Fermion

2004–2006  Orion Pharma, Senior Vice President, Supply Chain
2004–2005  Fermion Oy, President
2002–2004  Orion Pharma, Senior Vice President, Supply Chain
2000–2002  Orion Pharma, Programme Director, business processes and
                       information systems
1998–2000  Orion Pharma, Vice President, International Sales
1996–1998  Orion Pharma, Director and Vice President, Materials Management
1991–1996  Orion-Farmos Pharmaceuticals, Director, Materials Management
1990–1991  Farmos Oy, Pharmaceutical Division, Director and Vice President,
                       Materials Management
1987–1990  Farmos Oy, Materials Manager
1984–1987  Farmos Oy, Plant Manager
1982–1983  Farmos Oy, Production Planning Manager

1981–1982  Oy Santasalo-Sohlberg Ab, Development Engineer

 

Current key positions of trust

Member of the Board: Pharmaservice Oy 2011–
Member of Health Cluster of the National Emergency Supply Organisation, NESO 2007–


 

 


Olli Huotari
Master of Laws, LL.M.
b. 1966

Senior Vice President, Corporate Functions (Communications, Human Resources, Intellectual Property Rights and Legal Affairs), since 1 July 2006

 

Secretary to the Board of Directors of Orion Corporation, since 1 October 2002

  

 

Career

Olli Huotari joined Orion in 1996. He has since occupied the following positions:

2006–           Senior Vice President, Corporate Functions

2005–2006  Vice President, Human Resources at Orion Pharma and Corporate
                       Vice President, HR development of the Orion Group
2002–2006  General Counsel of the Orion Group
1996–2002  Legal Counsel in Corporate Administration

1992–1995  Law firm Asianajotoimisto Jouko Penttilä Oy, Legal Counsel

 

In 1995–1996, Olli Huotari completed the degree of Master of Laws in International Commercial Law at the University of Kent at Canterbury, UK.

 

   

Liisa Hurme
Ph. D. (Biochemistry) 
b. 1967 

Senior Vice President, Proprietary Products, since 1 January 2008

 

  

Career
Liisa Hurme joined Orion in 1999. She has since occupied the following positions:
2008–           Senior Vice President, Proprietary Products
2005–2007  Head of Urology and Oncology business
2004–2005  Program Leader of pharmaceutical development projects for Hormonal
                       and Urological therapies
2002–2004  Portfolio Manager
2001–2002  Project Manager
1999–2001  Researcher and Project Manager, Hormonal therapies
1995–1999  Pharmacia & Upjohn, Researcher, Diagnostics Unit (Sweden) and
                       Researcher, Development projects at ELIAS GmbH (Germany)
                       and Institute Pasteur (France)

 

Liisa Hurme completed her doctoral thesis on biochemistry at the University of Helsinki, Faculty of Science, in 1996.


Current key positions of trust

Member of the Board of Finnish Bioindustries FIB 2010–
Member of the Economic & Social Policy Committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA) 2010–

 

 

 

Jari Karlson
M.Sc. (Econ.)
b. 1961

Chief Financial Officer (CFO), since 1 August 2002

 

 

  

Career
2002–           Chief Financial Officer (CFO)
2001–2002  Orion Pharma, Vice President, Finance
1999–2001  Kuusakoski Group Oy, Vice President, Finance
1990–1999  Genencor International Inc, Controller, Director of Planning for the
                       Europe and Asia region and Director of Finance in Europe
1988–1989  Cultor Oy, Financial controller for the Biochem division

 

As of November 2010, CFO Jari Karlson also takes the executive responsibility of the Animal Health business division.

 

Current key positions of trust

Member of the Board: Tapiola Mutual Pension Insurance Company 2010–, Finnish Foundation of Veterinary Research 2011–

 

 

 

 

Virve Laitinen
M.Sc. (Tech.), MBA 
b. 1972

Senior Vice President, Supply Chain, since 1 January 2012

 

 
 

Career
Virve Laitinen joined Orion in 1997. She has since occupied the following positions:
2012–           Senior Vice President, Supply Chain
2007–2011  Finance, Director, Business Planning and Control
2001–2006  Supply Chain, Manager, Industrialisation and Contract Manufacturing
1997–2000  Supply Chain, Development Engineer

 

 

 

Reijo Salonen
Professor, Docent, MD, PhD
b. 1956

Senior Vice President, Research and Development and Chief Medical Officer, since 1 November 2006

 


 

Career

2006–              Orion Corporation, Senior Vice President, Research and Development and Chief Medical Officer

2004–2006     Pfizer, Vice President, Neurology, Psychiatry and Ophthalmology and Worldwide Therapeutic Area Head Neurosciences (USA)

2002–2004     GlaxoSmithKline, Vice President, Clinical Development and Medical
Affairs, Neurosciences

2001–2002     GlaxoSmithKline, Vice President, Clinical Development, Neurology and GI

1999–2001     GlaxoWellcome, Director, Medical Strategy and Communications in the Neurosciences Therapy Group

1998–1999     GlaxoWellcome, Principal Medical Strategy Head in Neurology and Psychiatry

1997–1998     GlaxoWellcome, Senior Medical Strategy Head, Neurology (USA)

1995–1997     GlaxoWellcome, Country Medical Director (Finland)

 

Current key positions of trust

Member of the Board of Directors: The Finnish Medical Foundation 2011–

Member: European Brain Council Industry Board 2006–, European Federation of Pharmaceutical Industries and Associations (EFPIA), Research Directors Group  2007–, University of Turku, External Advisory Board 2010– 

 

Former key positions of trust

Member of the Board: European Brain Council 2006–2010

 

Reijo Salonen received both his MD degree and PhD (in Neuroimmunology) from the University of Turku in1983. He is Specialist in Neurology and has been Docent in Neuroimmunology at Turku since 1989.  He received the Finnish honorary title of Professor in 2009.

 

 

 

Liisa Remes
Research Assistant

 
Liisa Remes is the employee representative in the Executive Management Board.

 

 

 

Updated Mar 8th 2012